Evotec SE EVO
NASDAQ EVO
$1.67 +0.05 (+3.09%)
At close: Sep 17, 2026 · 4:00 PM EDT

Evotec SE (EVO) EBIT Margin Growth (1y) (2010 - 2025)

Analysis

Evotec SE (EVO) EBIT Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -101.00
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -18.00
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -465.00
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 224.00
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 4,868.00
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn -14,185.00
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 108.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -21.83 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - -744,940.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1,239.00
Sep 30, 2025 -1,283.00
Jun 30, 2025 -6,643.00
Mar 31, 2025 -128.00
Dec 31, 2024 620,132.00
Jun 30, 2024 6,720.00
Dec 31, 2023 -619,550.00
Jun 30, 2023 -1,480.00
Dec 31, 2022 -993.00
Sep 30, 2022 -1.11 Mn
Jun 30, 2022 -330.00
Mar 31, 2022 -481,182.00
Dec 31, 2021 -305.00
Sep 30, 2021 -153,769.00
Dec 31, 2020 -545.00
Jun 30, 2010 9,645.00
Mar 31, 2010 -26,078.00